Event Details
February 01, 2019
Description
Amyris announcement of partnership agreement.
Participants (3)
| Name | Type | Mentions | |
|---|---|---|---|
| Amyris | person | 0 | View Entity |
| Undisclosed Partner | person | 0 | View Entity |
| Amyris | organization | 9 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024836.jpg
This document is page 20 of a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. It details the scientific process of biosynthetic cannabinoid production via fermentation and highlights a specific February 2019 business deal where Amyris signed a partnership valued at up to $255 million with an 'undisclosed partner.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.
Related Events
Events with shared participants
Amyris announced a $255 million cannabinoid development, licensing and commercialization agreement.
2019-02-25 • N/A
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event